CIK 0001604464 · Non-accelerated filer<br>Smaller reporting company
Atara Biotherapeutics, Inc.
Sign in to watch- Ticker
- ATRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460920988
- Phone
- 805-623-4211
- Business address
- 1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
- Open-market buys, last 90 days
- $999,994
- in 1 filing
- Open-market sales, last 90 days
- $40,883
- in 1 filing
Net +$959,111. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-01 | Dupont Jakob EVP, Head of R&D | Grant or award | +141,328 | 295,868 | ||
| 2023-03-01 | Dupont Jakob EVP, Head of R&D | Grant or award · Employee Stock Option (Right to Buy) | +317,987 | 317,987 | ||
| 2023-03-01 | Murugan Amar SVP, GC & Secretary | Grant or award | +155,375 | 283,555 | ||
| 2023-03-01 | Murugan Amar SVP, GC & Secretary | Grant or award · Employee Stock Option (Right to Buy) | +349,593 | 349,593 | ||
| 2023-02-07 | Koppikar Utpal Chief Financial Officer | Sale | −2,485 | $5.46 | $14K | 188,849 |
| 2022-11-16 | Dupont Jakob EVP, Head of R&D | Sale | −3,218 | $4.49 | $14K | 155,664 |
| 2022-11-16 | Dupont Jakob EVP, Head of R&D | Sale | −1,124 | $4.49 | $5K | 154,540 |
| 2022-11-16 | Touchon Pascal President and CEO | Sale | −15,591 | $4.49 | $70K | 441,696 |
| 2022-11-16 | Murugan Amar SVP, GC & Secretary | Sale | −3,612 | $4.49 | $16K | 127,586 |
| 2022-11-16 | Koppikar Utpal Chief Financial Officer | Sale | −5,172 | $4.49 | $23K | 192,417 |
| 2022-11-16 | Koppikar Utpal Chief Financial Officer | Sale | −1,083 | $4.49 | $5K | 191,334 |
| 2022-08-16 | Touchon Pascal President and CEO | Sale | −14,806 | $5.04 | $75K | 457,287 |
| 2022-08-16 | Dupont Jakob EVP, Head of R&D | Sale | −4,124 | $5.03 | $21K | 158,882 |
| 2022-08-16 | Murugan Amar SVP, GC & Secretary | Sale | −1,196 | $5.03 | $6K | 133,432 |
| 2022-08-16 | Murugan Amar SVP, GC & Secretary | Sale | −2,234 | $5.04 | $11K | 131,198 |
| 2022-08-16 | Koppikar Utpal Chief Financial Officer | Sale | −5,940 | $5.04 | $30K | 197,589 |
| 2022-06-27 | Touchon Pascal President and CEO | Sale | −14,220 | $7.20 | $102K | 472,093 |
| 2022-06-23 | Gallagher Carol Giltner Director | Grant or award | +20,500 | 132,418 | ||
| 2022-06-23 | Gallagher Carol Giltner Director | Grant or award · Non-Qualified Stock Option (Right to Buy) | +31,500 | 31,500 | ||
| 2022-06-23 | HEIDEN WILLIAM K Director | Grant or award | +20,500 | 52,000 |
Page 9 of 17 · 334 trades